XTL Biopharmaceuticals Grieves the Death of Board Member Jonathan Spicehandler, MD
01 August 2006 - 6:19PM
PR Newswire (US)
NEW YORK, New York, August 1 /PRNewswire-FirstCall/ -- XTL
Biopharmaceuticals Ltd. (NASDAQ:XTLB)(LSE:XTL)(TASE:XTL) mourns the
loss of board member Jonathan Spicehandler, MD. Dr. Spicehandler
passed away on July 30, 2006, after a long battle with brain
cancer. A member of XTL's board since February 2005, Dr.
Spicehandler had an illustrious pharmaceutical career, most
recently serving as Chairman of Schering-Plough Research Institute,
the pharmaceutical research arm of Schering-Plough Corporation. Dr.
Spicehandler was a prolific researcher and played a leading role in
the development and approval of several, important drugs that are
used today to treat millions of people. "We are deeply saddened by
the untimely passing of Jonathan Spicehandler" said Ron Bentsur,
CEO of XTL. "His leadership and experience, and above all,
friendship, will be sorely missed. Jonathan will continue to be an
inspiration to all of us. Our deepest condolences go out to his
wife and children." Contact: Ron Bentsur Chief Executive Officer
+1-(212)-531-5960 DATASOURCE: XTL Biopharmaceuticals Ltd CONTACT:
Contact: Ron Bentsur, Chief Executive Officer, +1-(212)-531-5960,
Copyright
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jun 2024 to Jul 2024
XTL Biopharmaceuticals (NASDAQ:XTLB)
Historical Stock Chart
From Jul 2023 to Jul 2024